Page 3 - Pharma Stocks
Why Nomura continues to back Glenmark Pharma; Retains 'Buy'; Find out here
Analysts at Nomura continue to back Glenmark Pharma, citing the company's ability to strategically acquire high-potential innovative products.
 "Why Nomura continues to back Glenmark Pharma; Retains 'Buy'; Find out here")
Sun Pharmaceutical: Domestic, innovation push eyed; Nuvama maintains 'Hold'
Sun Pharma aims to strengthen its domestic formulations business through field force expansion and a generic GLP-1 launch in CY26.
 "Sun Pharmaceutical: Domestic, innovation push eyed; Nuvama maintains 'Hold'")
Shilpa Medicare hits 5% upper circuit; here's what sparked the rally today
Around 1:30 PM, Shilpa Medicare shares continued to trade 2.04 per cent higher at ₹833.95 per share. In comparison, BSE Sensex was trading flat at 82,176.17 levels.
 "Shilpa Medicare hits 5% upper circuit; here's what sparked the rally today")
Natco Pharma surges 5% after USFDA classifies Hyderabad facility as VAI
Natco Pharma stock was trading at ₹884.5, up 3.2 per cent compared to the previous session's close of ₹857.25 on the NSE
 "Natco Pharma surges 5% after USFDA classifies Hyderabad facility as VAI")
Cohance Lifesciences shares slide 8% on block deals; Likely seller here
Cohance Lifesciences shares fell the most since August 14, after about 8.9 per cent stake changed hands on the NSE
 "Cohance Lifesciences shares slide 8% on block deals; Likely seller here")
Pharma in bitter health: Stocks sink upto 38% in 2025; time to bottom fish?
Among stocks, Natco Pharma plunged 37.85%, Ipca Labs 22.43%, Aurobindo Pharma 17.99%, and Sun Pharma 14.30%. Other laggards include Lupin (13.25%), and Dr Reddy's (5.17%).
 "Pharma in bitter health: Stocks sink upto 38% in 2025; time to bottom fish?")
Dr Reddy's shares fall as USFDA flags Hyderabad plant with 5 observations
Dr Reddy's shares fell on Monday after the USFDA issued a Form 483 with five observations at its Hyderabad plant inspection
 "Dr Reddy's shares fall as USFDA flags Hyderabad plant with 5 observations")
Blue Jet Healthcare down 4% as promoter launches OFS at ₹675; check details
Blue Jet Healthcare's share price was trading 3.55 per cent lower at ₹704.8 per share compared to previous day's close of ₹730 on the NSE
 "Blue Jet Healthcare down 4% as promoter launches OFS at ₹675; check details")
Laurus Labs gains 3%, nears record high; should you buy, hold or sell?
Thus far in September, the stock price of Laurus Labs has rallied 6 per cent, as compared to a 1.5 per cent rise in the BSE Sensex and BSE Healthcare index
 "Laurus Labs gains 3%, nears record high; should you buy, hold or sell?")
Glenmark Pharma up 3% on DCGI nod to start phase 3 trial of Envafolimab
Around 11:20 PM, Glenmark Pharmaceuticals shares continued to trade higher, up 3.05 per cent at ₹2,051.40 per share. In comparison, BSE Sensex was trading 0.25 per cent lower at 80,518.51 levels.
Biocon shares gain 2% after USFDA inspection at Bengaluru facility; details
The inspection covered various aspects of operations including drug substance manufacturing units, analytical quality control laboratories, microbiology laboratories, and warehouses
 "Biocon shares gain 2% after USFDA inspection at Bengaluru facility; details")
Pharma stock up 37% in 6 mths; Nuvama initiates with 'Buy', eyes 29% gains
According to Nuvama analysts Shrikant Akolkar, Aashita Jain and Gaurav Lakhotia, the company is positioned for robust growth over the medium-term, driven by capacity expansion and product additions.
Lupin share price rises 3% as USFDA okays schizophrenia drug; details
Drugmaker Lupin said it has received the USFDA's approval for Risperidone for extended-release injectable suspension
 "Lupin share price rises 3% as USFDA okays schizophrenia drug; details")
Anlon Healthcare makes flat D-street debut, lists at ₹92 on NSE SME
Post-listing, the Anlon Healthcare stock was trading at ₹91.5, up 0.55 per cent from the listing price on the BSE
 "Anlon Healthcare makes flat D-street debut, lists at ₹92 on NSE SME")
Dr Agarwal's Health Care, Eye Hospital shares tumble up to 17%; here's why
Dr Agarwal's Eye Hospital shares fell 17.7 per cent, while Dr Agarwal's Health Care slid 6.83 per cent on the merger announcement
 "Dr Agarwal's Health Care, Eye Hospital shares tumble up to 17%; here's why")
Sun Pharma slips 5% in 2 days, nears 52-wk low; why drug stock trades weak?
Thus far in August 2025, Sun Pharma has underperformed the market by falling 8 per cent, as compared to a 1 per cent decline in the BSE Sensex
 "Sun Pharma slips 5% in 2 days, nears 52-wk low; why drug stock trades weak?")
SMS Pharmaceuticals shares zoom 10% on clean USFDA inspection report
SMS Pharmaceuticals shares rose 10 per cent after it received an Establishment Inspection Report with a No Action Indicated from the USFDA
 "SMS Pharmaceuticals shares zoom 10% on clean USFDA inspection report")
Concord Biotech shares jump 6 per cent; here's what is fueling the gains
The upward movement in the pharmaceutical company's stock price followed an announcement regarding the company's Limbasi API facility
 "Concord Biotech shares jump 6 per cent; here's what is fueling the gains")
Marksans Pharma gains 3% on UK MHRA approval for subsidiary; details here
The upward movement in Marksans Pharma's share price came after the company announced that its wholly owned subsidiary, Relonchem in the UK, had received marketing authorisation for its products
 "Marksans Pharma gains 3% on UK MHRA approval for subsidiary; details here")
Shilpa Medicare share jumps 4% on 1:1 bonus issue; check record date here
Shilpa Medicare shares rose after the company announced a 1:1 bonus issue, with the Board approving the proposal in its meeting on August 13, 2025.
